,50 Therapeutically inhibiting SARM1 may therefore be a putatively viable strategy for treating neurodegenerative diseases characterized by axon loss, such as amyotrophic lateral sclerosis.42 The gene discussed is SARM1; the disease is neurodegenerative disease.